Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander hoofdstuk

2022 | OriginalPaper | Hoofdstuk

5. Spieren en spierfunctie

Auteur: Prof. dr. I. Bautmans

Gepubliceerd in: Geriatrie in de fysiotherapie en kinesitherapie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Initieel werd sarcopenie gedefinieerd als leeftijdsgebonden afname in spiermassa. Operationele definities voor sarcopenie omvatten functieverlies in aanwezigheid van spierzwakte en/of spieratrofie. De pathofysiologie is multifactorieel en een nauwe samenhang met inflammatoire processen werd aangetoond. Sarcopenie verergert door een complexe interactie tussen veroudering, ondergebruik, immobilisatie, ziekte en ondervoeding. Aan de hand van een uitgebreid geriatrisch assessment kan de relatieve bijdrage van deze factoren worden bepaald en een adequate behandelstrategie worden ontwikkeld. Intensieve krachttraining is thans de meest efficiënte behandeling voor sarcopenie, zelfs bij zeer oude geriatrische patiënten. Significante verbeteringen (tot > 50 % krachtswinst) kunnen verwacht worden na zes weken training aan 2–3 sessies per week. Vanuit een preventief oogpunt zou alle oudere patiënten geadviseerd moeten worden om een dergelijk oefenprogramma op te starten en vol te houden. Naast effecten ter hoogte van de spier zelf, worden ook systemische reacties uitgelokt door spierkrachttraining, waaronder een betere cellulaire bescherming en een verlaging van het inflammatoir profiel.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol. 2000;89(1):81–8. PubMedCrossRef Janssen I, Heymsfield SB, Wang ZM, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18–88 yr. J Appl Physiol. 2000;89(1):81–8. PubMedCrossRef
2.
3.
go back to reference Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutrition. 1997;127(5 Suppl):990S-1S. CrossRef Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutrition. 1997;127(5 Suppl):990S-1S. CrossRef
4.
go back to reference Morley JE. Editorial: the top 10 hot topics in aging. J Gerontol A Biol Sci Med Sci. 2004;59A(1):24–33. CrossRef Morley JE. Editorial: the top 10 hot topics in aging. J Gerontol A Biol Sci Med Sci. 2004;59A(1):24–33. CrossRef
5.
go back to reference Sehl ME, Yates FE. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci. 2001;56(5):B198–208. Sehl ME, Yates FE. Kinetics of human aging: I. Rates of senescence between ages 30 and 70 years in healthy people. J Gerontol A Biol Sci Med Sci. 2001;56(5):B198–208.
6.
go back to reference Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2–3):275–94. PubMedCrossRef Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci. 1988;84(2–3):275–94. PubMedCrossRef
7.
go back to reference Marcell TJ. Review article: sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci. 2003;58(10):M911-6. PubMedCrossRef Marcell TJ. Review article: sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci. 2003;58(10):M911-6. PubMedCrossRef
8.
go back to reference Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol. 1991;71(2):644–50. PubMedCrossRef Frontera WR, Hughes VA, Lutz KJ, Evans WJ. A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women. J Appl Physiol. 1991;71(2):644–50. PubMedCrossRef
9.
go back to reference Narici MV, Maganaris CN. Plasticity of the muscle-tendon complex with disuse and aging. Exerc Sport Sci Rev. 2007;35(3):126–34. PubMedCrossRef Narici MV, Maganaris CN. Plasticity of the muscle-tendon complex with disuse and aging. Exerc Sport Sci Rev. 2007;35(3):126–34. PubMedCrossRef
10.
go back to reference Aniansson A, Grimby G, Hedberg M. Compensatory muscle fiber hypertrophy in elderly men. J Appl Physiol. 1992;73(3):812–6. PubMedCrossRef Aniansson A, Grimby G, Hedberg M. Compensatory muscle fiber hypertrophy in elderly men. J Appl Physiol. 1992;73(3):812–6. PubMedCrossRef
11.
go back to reference Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39(5):687–99. PubMedCrossRef Krabbe KS, Pedersen M, Bruunsgaard H. Inflammatory mediators in the elderly. Exp Gerontol. 2004;39(5):687–99. PubMedCrossRef
12.
go back to reference Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012;15(1):12–22. PubMedCrossRef Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care. 2012;15(1):12–22. PubMedCrossRef
13.
go back to reference Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med. 2001;68(6):535–7. PubMedCrossRef Kushner I. C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging. Cleve Clin J Med. 2001;68(6):535–7. PubMedCrossRef
14.
go back to reference Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57(5):M326-32. PubMedCrossRef Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57(5):M326-32. PubMedCrossRef
15.
go back to reference Payette H, Roubenoff R, Jacques PF, Dinarello CA, Wilson PW, Abad LW, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc. 2003;51(9):1237–43. PubMedCrossRef Payette H, Roubenoff R, Jacques PF, Dinarello CA, Wilson PW, Abad LW, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc. 2003;51(9):1237–43. PubMedCrossRef
16.
go back to reference Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol. 2003;38(9):981–7. PubMedCrossRef Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol. 2003;38(9):981–7. PubMedCrossRef
17.
go back to reference Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851–60. PubMedCrossRef Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851–60. PubMedCrossRef
18.
go back to reference Trappe S, Gallagher P, Harber M, Carrithers J, Fluckey J, Trappe T. Single muscle fibre contractile properties in young and old men and women. J Physiol. 2003;552(1):47–58. PubMedPubMedCentralCrossRef Trappe S, Gallagher P, Harber M, Carrithers J, Fluckey J, Trappe T. Single muscle fibre contractile properties in young and old men and women. J Physiol. 2003;552(1):47–58. PubMedPubMedCentralCrossRef
19.
go back to reference Avery NC, Bailey AJ. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand J Med Sci Sports. 2005;15(4):231–40. PubMedCrossRef Avery NC, Bailey AJ. Enzymic and non-enzymic cross-linking mechanisms in relation to turnover of collagen: relevance to aging and exercise. Scand J Med Sci Sports. 2005;15(4):231–40. PubMedCrossRef
20.
go back to reference Lee CE, McArdle A, Griffiths RD. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clinical nutrition (Edinburgh, Scotland). 2007;26(5):524–34. CrossRef Lee CE, McArdle A, Griffiths RD. The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clinical nutrition (Edinburgh, Scotland). 2007;26(5):524–34. CrossRef
21.
go back to reference Njemini R, Bautmans I, Lambert M, Demanet C, Mets T. Heat shock proteins and chemokine/cytokine secretion profile in ageing and inflammation. Mech Ageing Dev. 2007;128(7–8):450–4. PubMedCrossRef Njemini R, Bautmans I, Lambert M, Demanet C, Mets T. Heat shock proteins and chemokine/cytokine secretion profile in ageing and inflammation. Mech Ageing Dev. 2007;128(7–8):450–4. PubMedCrossRef
22.
go back to reference Njemini R, Lambert M, Demanet C, Kooijman R, Mets T. Basal and infection-induced levels of heat shock proteins in human aging. Biogerontology. 2007. Njemini R, Lambert M, Demanet C, Kooijman R, Mets T. Basal and infection-induced levels of heat shock proteins in human aging. Biogerontology. 2007.
23.
go back to reference Njemini R, Lambert M, Demanet C, Mets T. Heat shock protein 32 in human peripheral blood mononuclear cells: effect of aging and inflammation. J Clin Immunol. 2005;25(5):405–17. PubMedCrossRef Njemini R, Lambert M, Demanet C, Mets T. Heat shock protein 32 in human peripheral blood mononuclear cells: effect of aging and inflammation. J Clin Immunol. 2005;25(5):405–17. PubMedCrossRef
24.
go back to reference Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol. 2006;41(3):312–9. PubMedCrossRef Njemini R, Lambert M, Demanet C, Mets T. The effect of aging and inflammation on heat shock protein 27 in human monocytes and lymphocytes. Exp Gerontol. 2006;41(3):312–9. PubMedCrossRef
25.
go back to reference Njemini R, Abeele MV, Demanet C, Lambert M, Vandebosch S, Mets T. Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol. 2002;22(4):195–205. PubMedCrossRef Njemini R, Abeele MV, Demanet C, Lambert M, Vandebosch S, Mets T. Age-related decrease in the inducibility of heat-shock protein 70 in human peripheral blood mononuclear cells. J Clin Immunol. 2002;22(4):195–205. PubMedCrossRef
26.
go back to reference Njemini R, Demanet C, Mets T. Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during aging. Biogerontology. 2004;5(1):31–8. PubMedCrossRef Njemini R, Demanet C, Mets T. Inflammatory status as an important determinant of heat shock protein 70 serum concentrations during aging. Biogerontology. 2004;5(1):31–8. PubMedCrossRef
27.
go back to reference Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med. 2000;343(2):108–17. Delves PJ, Roitt IM. The immune system. Second of two parts. N Engl J Med. 2000;343(2):108–17.
28.
go back to reference Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308(10):553–8. Baracos V, Rodemann HP, Dinarello CA, Goldberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med. 1983;308(10):553–8.
30.
go back to reference Zoico E, Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev. 2002;60(2):39–51. PubMedCrossRef Zoico E, Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev. 2002;60(2):39–51. PubMedCrossRef
31.
go back to reference Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996;335(25):1897–905. Mitch WE, Goldberg AL. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N Engl J Med. 1996;335(25):1897–905.
32.
go back to reference Argiles JM, Alvarez B, Carbo N, Busquets S, Van Royen M, Lopez-Soriano FJ. The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw. 2000;11(4):552–9. PubMed Argiles JM, Alvarez B, Carbo N, Busquets S, Van Royen M, Lopez-Soriano FJ. The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw. 2000;11(4):552–9. PubMed
33.
go back to reference Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Directors Assoc. 2013;14(8):542–59. CrossRef Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Directors Assoc. 2013;14(8):542–59. CrossRef
34.
go back to reference Paddon-Jones D, Campbell WW, Jacques PF, Kritchevsky SB, Moore LL, Rodriguez NR, et al. Protein and healthy aging. Am J Clin Nutr. 2015. Paddon-Jones D, Campbell WW, Jacques PF, Kritchevsky SB, Moore LL, Rodriguez NR, et al. Protein and healthy aging. Am J Clin Nutr. 2015.
35.
go back to reference Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Asp Med. 2005;26:203–19. CrossRef Montero-Odasso M, Duque G. Vitamin D in the aging musculoskeletal system: an authentic strength preserving hormone. Mol Asp Med. 2005;26:203–19. CrossRef
36.
37.
go back to reference Drieskens S, Nguyen D, Gisle L. Gezondheidsenquête 2018: Lichaamsbeweging. Sciensano; 2018. Report No.: D/2019/14.440/54. Drieskens S, Nguyen D, Gisle L. Gezondheidsenquête 2018: Lichaamsbeweging. Sciensano; 2018. Report No.: D/2019/14.440/54.
38.
go back to reference Hawkins SA, Wiswell RA, Marcell TJ. Exercise and the master athlete–a model of successful aging? J Gerontol A Biol Sci Med Sci. 2003;58(11):1009–11. PubMedCrossRef Hawkins SA, Wiswell RA, Marcell TJ. Exercise and the master athlete–a model of successful aging? J Gerontol A Biol Sci Med Sci. 2003;58(11):1009–11. PubMedCrossRef
39.
go back to reference Wiswell RA, Hawkins SA, Jaque SV, Hyslop D, Constantino N, Tarpenning K, et al. Relationship between physiological loss, performance decrement, and age in master athletes. J Gerontol A Biol Sci Med Sci. 2001;56(10):M618-26. PubMedCrossRef Wiswell RA, Hawkins SA, Jaque SV, Hyslop D, Constantino N, Tarpenning K, et al. Relationship between physiological loss, performance decrement, and age in master athletes. J Gerontol A Biol Sci Med Sci. 2001;56(10):M618-26. PubMedCrossRef
40.
go back to reference Meltzer DE. Age dependence of Olympic weightlifting ability. Med Sci Sports Exerc. 1994;26(8):1053–67. PubMedCrossRef Meltzer DE. Age dependence of Olympic weightlifting ability. Med Sci Sports Exerc. 1994;26(8):1053–67. PubMedCrossRef
41.
go back to reference Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, et al. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 1990;140(1):41–54. PubMedCrossRef Klitgaard H, Mantoni M, Schiaffino S, Ausoni S, Gorza L, Laurent-Winter C, et al. Function, morphology and protein expression of ageing skeletal muscle: a cross-sectional study of elderly men with different training backgrounds. Acta Physiol Scand. 1990;140(1):41–54. PubMedCrossRef
42.
go back to reference Brown M. The master athlete. Orthop Phys Ther Clin N Am. 1997;6(3):253–66. Brown M. The master athlete. Orthop Phys Ther Clin N Am. 1997;6(3):253–66.
43.
go back to reference Hurley MV, Rees J, Newham DJ. Quadriceps function, proprioceptive acuity and functional performance in healthy young, middle-aged and elderly subjects. Age Ageing. 1998;27(1):55–62. PubMedCrossRef Hurley MV, Rees J, Newham DJ. Quadriceps function, proprioceptive acuity and functional performance in healthy young, middle-aged and elderly subjects. Age Ageing. 1998;27(1):55–62. PubMedCrossRef
44.
go back to reference Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):56–62. PubMedCrossRef Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc. 2006;54(1):56–62. PubMedCrossRef
45.
go back to reference Hortobagyi T, Mizelle C, Beam S, DeVita P. Old adults perform activities of daily living near their maximal capabilities. J Gerontol A Biol Sci Med Sci. 2003;58(5):M453-60. PubMedCrossRef Hortobagyi T, Mizelle C, Beam S, DeVita P. Old adults perform activities of daily living near their maximal capabilities. J Gerontol A Biol Sci Med Sci. 2003;58(5):M453-60. PubMedCrossRef
46.
go back to reference Mets T, Bautmans I, Njemini R, Lambert M, Demanet C. The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. Am J Geriatr Pharmacother. 2004;2(4):230–8. PubMedCrossRef Mets T, Bautmans I, Njemini R, Lambert M, Demanet C. The influence of celecoxib on muscle fatigue resistance and mobility in elderly patients with inflammation. Am J Geriatr Pharmacother. 2004;2(4):230–8. PubMedCrossRef
47.
go back to reference Bautmans I, Njemini R, Lambert M, Demanet C, Mets T. Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients. J Gerontol A Biol Sci Med Sci. 2005;60(3):361–7. PubMedCrossRef Bautmans I, Njemini R, Lambert M, Demanet C, Mets T. Circulating acute phase mediators and skeletal muscle performance in hospitalized geriatric patients. J Gerontol A Biol Sci Med Sci. 2005;60(3):361–7. PubMedCrossRef
48.
go back to reference Hoenig H, Rubenstein LZ. Hospital-associated deconditioning and dysfunction. J Am Geriatr Soc. 1991;39:220–2. PubMedCrossRef Hoenig H, Rubenstein LZ. Hospital-associated deconditioning and dysfunction. J Am Geriatr Soc. 1991;39:220–2. PubMedCrossRef
49.
go back to reference Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–5. PubMedCrossRef Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52(1):80–5. PubMedCrossRef
50.
go back to reference Mijnarends DM, Schols JMGA, Halfens RJG, Meijers JMM, Luiking YC, Verlaan S, et al. Burden-of-illness of Dutch community-dwelling older adults with sarcopenia: Health related outcomes and costs. Euro Geriatr Med. 2016;7(3):276–84. CrossRef Mijnarends DM, Schols JMGA, Halfens RJG, Meijers JMM, Luiking YC, Verlaan S, et al. Burden-of-illness of Dutch community-dwelling older adults with sarcopenia: Health related outcomes and costs. Euro Geriatr Med. 2016;7(3):276–84. CrossRef
52.
go back to reference Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–63. PubMedCrossRef Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147(8):755–63. PubMedCrossRef
53.
go back to reference Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889–96. PubMedCrossRef Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50(5):889–96. PubMedCrossRef
54.
go back to reference Bautmans I, Van Puyvelde K, Mets T. Sarcopenia and functional decline: pathophysiology, prevention and therapy. Acta Clin Belg. 2009;64(4):303–16. PubMedCrossRef Bautmans I, Van Puyvelde K, Mets T. Sarcopenia and functional decline: pathophysiology, prevention and therapy. Acta Clin Belg. 2009;64(4):303–16. PubMedCrossRef
55.
go back to reference Gallagher D, Ruts E, Visser M, Heshka S, Baumgartner RN, Wang J, et al. Weight stability masks sarcopenia in elderly men and women. Am J Physiol. 2000;279(2):E366-75. Gallagher D, Ruts E, Visser M, Heshka S, Baumgartner RN, Wang J, et al. Weight stability masks sarcopenia in elderly men and women. Am J Physiol. 2000;279(2):E366-75.
56.
go back to reference Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23. PubMedPubMedCentralCrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412–23. PubMedPubMedCentralCrossRef
57.
go back to reference Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Directors Assoc. 2011;12(4):249–56. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Directors Assoc. 2011;12(4):249–56.
58.
go back to reference Lauretani F, Bautmans I, De Vita F, Nardelli A, Ceda GP, Maggio M. Identification and treatment of older persons with sarcopenia. Aging Male. 2014:1–6. Lauretani F, Bautmans I, De Vita F, Nardelli A, Ceda GP, Maggio M. Identification and treatment of older persons with sarcopenia. Aging Male. 2014:1–6.
59.
go back to reference Dawson-Hughes B, Bischoff-Ferrari H. Considerations concerning the definition of sarcopenia. Osteoporos Int. 2016. Dawson-Hughes B, Bischoff-Ferrari H. Considerations concerning the definition of sarcopenia. Osteoporos Int. 2016.
60.
go back to reference McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update. J Bone Miner Res. 2015;30(4):588–92. PubMedCrossRef McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an update. J Bone Miner Res. 2015;30(4):588–92. PubMedCrossRef
61.
go back to reference Cederholm T, Morley JE. Sarcopenia: the new definitions. Curr Opin Clin Nutr Metab Care. 2015;18(1):1–4. PubMedCrossRef Cederholm T, Morley JE. Sarcopenia: the new definitions. Curr Opin Clin Nutr Metab Care. 2015;18(1):1–4. PubMedCrossRef
62.
go back to reference Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58. PubMedPubMedCentralCrossRef Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547–58. PubMedPubMedCentralCrossRef
63.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. PubMedCrossRef Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. PubMedCrossRef
64.
go back to reference Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67(1):28–40. PubMedCrossRef Manini TM, Clark BC. Dynapenia and aging: an update. J Gerontol A Biol Sci Med Sci. 2012;67(1):28–40. PubMedCrossRef
65.
go back to reference Vandewoude M, Bautmans I. Sarcopenia: Is It Preventable? In: Cruz-Jentoft A, Morley JE, editors. Sarcopenia: Wiley-Blackwell; 2012. pag. 324. Vandewoude M, Bautmans I. Sarcopenia: Is It Preventable? In: Cruz-Jentoft A, Morley JE, editors. Sarcopenia: Wiley-Blackwell; 2012. pag. 324.
66.
go back to reference Dam T-T, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol Ser A: Biologic Sci Med Sci. 2014;69(5):584–90. CrossRef Dam T-T, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J Gerontol Ser A: Biologic Sci Med Sci. 2014;69(5):584–90. CrossRef
67.
go back to reference Malmstrom TK, Miller DK, Herning MM, Morley JE. Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans. J Cachexia Sarcopenia Muscle. 2013;4(3):179–86. PubMedPubMedCentralCrossRef Malmstrom TK, Miller DK, Herning MM, Morley JE. Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African Americans. J Cachexia Sarcopenia Muscle. 2013;4(3):179–86. PubMedPubMedCentralCrossRef
68.
go back to reference Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. PubMedCrossRef Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle. 2016;7(1):28–36. PubMedCrossRef
69.
go back to reference Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Directors Assoc. 2013;14(8):531–2. CrossRef Malmstrom TK, Morley JE. SARC-F: a simple questionnaire to rapidly diagnose sarcopenia. J Am Med Directors Assoc. 2013;14(8):531–2. CrossRef
70.
go back to reference Merkies IS, Schmitz PI, Samijn JP, Meche FG, Toyka KV, Van Doorn PA. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve. 2000;23(9):1393–401. PubMedCrossRef Merkies IS, Schmitz PI, Samijn JP, Meche FG, Toyka KV, Van Doorn PA. Assessing grip strength in healthy individuals and patients with immune-mediated polyneuropathies. Muscle Nerve. 2000;23(9):1393–401. PubMedCrossRef
71.
go back to reference Yamada T, Ivarsson N, Hernández A, Fahlström A, Cheng AJ, Zhang S-J, et al. Impaired mitochondrial respiration and decreased fatigue resistance followed by severe muscle weakness in skeletal muscle of mitochondrial DNA mutator mice. J Physiol. 2012;590(23):6187–97. PubMedPubMedCentralCrossRef Yamada T, Ivarsson N, Hernández A, Fahlström A, Cheng AJ, Zhang S-J, et al. Impaired mitochondrial respiration and decreased fatigue resistance followed by severe muscle weakness in skeletal muscle of mitochondrial DNA mutator mice. J Physiol. 2012;590(23):6187–97. PubMedPubMedCentralCrossRef
72.
go back to reference De Dobbeleer L, Beyer I, Hansen AM, Molbo D, Mortensen EL, Lund R, et al. Grip Work Measurement with the Jamar Dynamometer: Validation of a Simple Equation for Clinical Use. J Nutr Health Aging. 2019;23(2):221–4. PubMedCrossRef De Dobbeleer L, Beyer I, Hansen AM, Molbo D, Mortensen EL, Lund R, et al. Grip Work Measurement with the Jamar Dynamometer: Validation of a Simple Equation for Clinical Use. J Nutr Health Aging. 2019;23(2):221–4. PubMedCrossRef
73.
go back to reference De Dobbeleer L, Beckwee D, Arnold P, Baudry S, Beyer I, Demarteau J, et al. Muscle fatigability measured with Pneumatic and Hydraulic handgrip systems are not interchangeable. Exp Gerontol. 2020;136:110950. De Dobbeleer L, Beckwee D, Arnold P, Baudry S, Beyer I, Demarteau J, et al. Muscle fatigability measured with Pneumatic and Hydraulic handgrip systems are not interchangeable. Exp Gerontol. 2020;136:110950.
74.
go back to reference De Dobbeleer L, Theou O, Beyer I, Jones GR, Jakobi JM, Bautmans I. Martin Vigorimeter assesses muscle fatigability in older adults better than the Jamar Dynamometer. Experimental Gerontol. 2018;111:65–70. CrossRef De Dobbeleer L, Theou O, Beyer I, Jones GR, Jakobi JM, Bautmans I. Martin Vigorimeter assesses muscle fatigability in older adults better than the Jamar Dynamometer. Experimental Gerontol. 2018;111:65–70. CrossRef
75.
go back to reference Bautmans I, Gorus E, Njemini R, Mets T. Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation. BMC Geriatr. 2007;7:5. PubMedPubMedCentralCrossRef Bautmans I, Gorus E, Njemini R, Mets T. Handgrip performance in relation to self-perceived fatigue, physical functioning and circulating IL-6 in elderly persons without inflammation. BMC Geriatr. 2007;7:5. PubMedPubMedCentralCrossRef
76.
go back to reference Bautmans I, Onyema O, Van Puyvelde K, Pleck S, Mets T. Grip work estimation during sustained maximal contraction: validity and relationship with dependency and inflammation in elderly persons. J Nutr Health Aging. 2011;15(8):731–6. PubMedCrossRef Bautmans I, Onyema O, Van Puyvelde K, Pleck S, Mets T. Grip work estimation during sustained maximal contraction: validity and relationship with dependency and inflammation in elderly persons. J Nutr Health Aging. 2011;15(8):731–6. PubMedCrossRef
77.
go back to reference Bautmans I, Njemini R, Predom H, Lemper JC, Mets T. Muscle endurance in elderly nursing home residents is related to fatigue perception, mobility, and circulating tumor necrosis factor-alpha, interleukin-6, and heat shock protein 70. J Am Geriatr Soc. 2008;56(3):389–96. PubMedCrossRef Bautmans I, Njemini R, Predom H, Lemper JC, Mets T. Muscle endurance in elderly nursing home residents is related to fatigue perception, mobility, and circulating tumor necrosis factor-alpha, interleukin-6, and heat shock protein 70. J Am Geriatr Soc. 2008;56(3):389–96. PubMedCrossRef
78.
go back to reference Gielen E, Beckwee D, Delaere A, De Breucker S, Vandewoude M, Bautmans I, et al. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2021;79(2):121–47. PubMedCrossRef Gielen E, Beckwee D, Delaere A, De Breucker S, Vandewoude M, Bautmans I, et al. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2021;79(2):121–47. PubMedCrossRef
79.
go back to reference De Spiegeleer A, Beckwee D, Bautmans I, Petrovic M, Sarcopenia Guidelines Development group of the Belgian Society of G, Geriatrics. Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Drugs Aging. 2018;35(8):719–34. De Spiegeleer A, Beckwee D, Bautmans I, Petrovic M, Sarcopenia Guidelines Development group of the Belgian Society of G, Geriatrics. Pharmacological interventions to improve muscle mass, muscle strength and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Drugs Aging. 2018;35(8):719–34.
80.
go back to reference Pedersen BK, Saltin B. Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1–72. PubMedCrossRef Pedersen BK, Saltin B. Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25(Suppl 3):1–72. PubMedCrossRef
81.
go back to reference Pate RR PM, Blair SN, Haskell WL, Macera CA,, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995(273):402–7. Pate RR PM, Blair SN, Haskell WL, Macera CA,, Bouchard C, et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995(273):402–7.
82.
go back to reference Peterson MD, Gordon PM. Resistance exercise for the aging adult: clinical implications and prescription guidelines. Am J Med. 2011;124(3):194–8. PubMedCrossRef Peterson MD, Gordon PM. Resistance exercise for the aging adult: clinical implications and prescription guidelines. Am J Med. 2011;124(3):194–8. PubMedCrossRef
83.
go back to reference Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev. 2010;9(3):226–37. PubMedPubMedCentralCrossRef Peterson MD, Rhea MR, Sen A, Gordon PM. Resistance exercise for muscular strength in older adults: a meta-analysis. Ageing Res Rev. 2010;9(3):226–37. PubMedPubMedCentralCrossRef
84.
go back to reference Peterson MD, Sen A, Gordon PM. Influence of resistance exercise on lean body mass in aging adults: a meta-analysis. Med Sci Sports Exerc. 2011;43(2):249–58. PubMedPubMedCentralCrossRef Peterson MD, Sen A, Gordon PM. Influence of resistance exercise on lean body mass in aging adults: a meta-analysis. Med Sci Sports Exerc. 2011;43(2):249–58. PubMedPubMedCentralCrossRef
85.
go back to reference Beckwee D, Delaere A, Aelbrecht S, Baert V, Beaudart C, Bruyere O, et al. Exercise interventions for the prevention and treatment of sarcopenia. A systematic umbrella review. J Nutr Health Aging. 2019;23(6):494–502. Beckwee D, Delaere A, Aelbrecht S, Baert V, Beaudart C, Bruyere O, et al. Exercise interventions for the prevention and treatment of sarcopenia. A systematic umbrella review. J Nutr Health Aging. 2019;23(6):494–502.
86.
go back to reference Stewart VH, Saunders DH, Greig CA. Responsiveness of muscle size and strength to physical training in very elderly people: a systematic review. Scand J Med Sci Sports. 2014;24(1):e1-10. PubMedCrossRef Stewart VH, Saunders DH, Greig CA. Responsiveness of muscle size and strength to physical training in very elderly people: a systematic review. Scand J Med Sci Sports. 2014;24(1):e1-10. PubMedCrossRef
87.
go back to reference Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 1990;263(22):3029–34. PubMedCrossRef Fiatarone MA, Marks EC, Ryan ND, Meredith CN, Lipsitz LA, Evans WJ. High-intensity strength training in nonagenarians. Effects on skeletal muscle. JAMA. 1990;263(22):3029–34. PubMedCrossRef
88.
go back to reference Arnold P, Bautmans I. The influence of strength training on muscle activation in elderly persons: a systematic review and meta-analysis. Exp Gerontol. 2014. Arnold P, Bautmans I. The influence of strength training on muscle activation in elderly persons: a systematic review and meta-analysis. Exp Gerontol. 2014.
89.
go back to reference Saini A, Faulkner S, Al-Shanti N, Stewart C. Powerful signals for weak muscles. Ageing Res Rev. 2009;8(4):251–67. PubMedCrossRef Saini A, Faulkner S, Al-Shanti N, Stewart C. Powerful signals for weak muscles. Ageing Res Rev. 2009;8(4):251–67. PubMedCrossRef
90.
91.
go back to reference Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clinica Chimica Acta. 2010;411(11–12):785–93. CrossRef Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clinica Chimica Acta. 2010;411(11–12):785–93. CrossRef
92.
go back to reference Bautmans I, Salimans L, Njemini R, Beyer I, Lieten S, Liberman K. The effects of exercise interventions on the inflammatory profile of older adults: a systematic review of the recent literature. Exp Gerontol. 2021:111236. Bautmans I, Salimans L, Njemini R, Beyer I, Lieten S, Liberman K. The effects of exercise interventions on the inflammatory profile of older adults: a systematic review of the recent literature. Exp Gerontol. 2021:111236.
94.
go back to reference Bautmans I, Njemini R, Vasseur S, Chabert H, Moens L, Demanet C, et al. Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology. 2005;51(4):253–65. PubMedCrossRef Bautmans I, Njemini R, Vasseur S, Chabert H, Moens L, Demanet C, et al. Biochemical changes in response to intensive resistance exercise training in the elderly. Gerontology. 2005;51(4):253–65. PubMedCrossRef
95.
go back to reference Bruunsgaard H, Pedersen BK. Effects of exercise on the immune system in the elderly population. Immunol Cell Biol. 2000;78(5):523–31. PubMedCrossRef Bruunsgaard H, Pedersen BK. Effects of exercise on the immune system in the elderly population. Immunol Cell Biol. 2000;78(5):523–31. PubMedCrossRef
96.
go back to reference Forti LN, Njemini R, Beyer I, Eelbode E, Meeusen R, Mets T, et al. Strength training reduces circulating interleukin-6 but not brain-derived neurotrophic factor in community-dwelling elderly individuals. Age (Dordr). 2014;36(5):9704. PubMedPubMedCentralCrossRef Forti LN, Njemini R, Beyer I, Eelbode E, Meeusen R, Mets T, et al. Strength training reduces circulating interleukin-6 but not brain-derived neurotrophic factor in community-dwelling elderly individuals. Age (Dordr). 2014;36(5):9704. PubMedPubMedCentralCrossRef
97.
go back to reference Forti LN, Van Roie E, Njemini R, Coudyzer W, Beyer I, Delecluse C, et al. Dose-and gender-specific effects of resistance training on circulating levels of brain derived neurotrophic factor (BDNF) in community-dwelling older adults. Exp Gerontol. 2015;70:144–9. PubMedCrossRef Forti LN, Van Roie E, Njemini R, Coudyzer W, Beyer I, Delecluse C, et al. Dose-and gender-specific effects of resistance training on circulating levels of brain derived neurotrophic factor (BDNF) in community-dwelling older adults. Exp Gerontol. 2015;70:144–9. PubMedCrossRef
98.
go back to reference Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun. 2011;25(5):811–6. PubMedCrossRef Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun. 2011;25(5):811–6. PubMedCrossRef
99.
go back to reference Bayingana K, Demarest S, Gisle L, Hesse E, Miermans P, Tafforeau J, et al. Gezondheidsenquête België 2004 Boek III Leefstijl. In: Wetenschappelijk Instituut Volksgezondheid AE, editor. 2006. pag. 1–115. Bayingana K, Demarest S, Gisle L, Hesse E, Miermans P, Tafforeau J, et al. Gezondheidsenquête België 2004 Boek III Leefstijl. In: Wetenschappelijk Instituut Volksgezondheid AE, editor. 2006. pag. 1–115.
100.
go back to reference Allender S, Cowburn G, Foster C. Understanding participation in sport and physical activity among children and adults: a review of qualitative studies. Health Educ Res Theory Pract. 2006;21(6):826–35. CrossRef Allender S, Cowburn G, Foster C. Understanding participation in sport and physical activity among children and adults: a review of qualitative studies. Health Educ Res Theory Pract. 2006;21(6):826–35. CrossRef
101.
go back to reference Baert V, Gorus E, Mets T, Geerts C, Bautmans I. Motivators and barriers for physical activity in the oldest old: a systematic review. Ageing Res Rev. 2011; In Press. Baert V, Gorus E, Mets T, Geerts C, Bautmans I. Motivators and barriers for physical activity in the oldest old: a systematic review. Ageing Res Rev. 2011; In Press.
102.
103.
go back to reference Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014. Cruz-Jentoft AJ, Landi F, Schneider SM, Zuniga C, Arai H, Boirie Y, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014.
104.
go back to reference Norheim KL, Cullum CK, Andersen JL, Kjaer M, Karlsen A. Inflammation relates to resistance training-induced hypertrophy in elderly patients. Med Sci Sports Exerc. 2017;49(6):1079–85. PubMedCrossRef Norheim KL, Cullum CK, Andersen JL, Kjaer M, Karlsen A. Inflammation relates to resistance training-induced hypertrophy in elderly patients. Med Sci Sports Exerc. 2017;49(6):1079–85. PubMedCrossRef
105.
go back to reference Ploeger HE, Takken T, De Greef MHG, Timmons BW. The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exercise Immunol Rev. 2009;15:6–41. Ploeger HE, Takken T, De Greef MHG, Timmons BW. The effects of acute and chronic exercise on inflammatory markers in children and adults with a chronic inflammatory disease: a systematic review. Exercise Immunol Rev. 2009;15:6–41.
106.
go back to reference Thomas VS, Hageman PA. Can neuromuscular strength and function in people with dementia be rehabilitated using resistance-exercise training? Results from a preliminary intervention study. J Gerontol A Biol Sci Med Sci. 2003;58(8):746–51. PubMedCrossRef Thomas VS, Hageman PA. Can neuromuscular strength and function in people with dementia be rehabilitated using resistance-exercise training? Results from a preliminary intervention study. J Gerontol A Biol Sci Med Sci. 2003;58(8):746–51. PubMedCrossRef
107.
go back to reference Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA. 2014. Pahor M, Guralnik JM, Ambrosius WT, Blair S, Bonds DE, Church TS, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA. 2014.
108.
go back to reference Said CM, Morris ME, Woodward M, Churilov L, Bernhardt J. Enhancing physical activity in older adults receiving hospital based rehabilitation: a phase II feasibility study. BMC Geriatr. 2012;12. Said CM, Morris ME, Woodward M, Churilov L, Bernhardt J. Enhancing physical activity in older adults receiving hospital based rehabilitation: a phase II feasibility study. BMC Geriatr. 2012;12.
109.
go back to reference Fiatarone Singh MA. Exercise, nutrition and managing hip fracture in older persons. Curr Opin Clin Nutr Metab Care. 2014;17(1):12–24. PubMed Fiatarone Singh MA. Exercise, nutrition and managing hip fracture in older persons. Curr Opin Clin Nutr Metab Care. 2014;17(1):12–24. PubMed
110.
go back to reference Baert V, Gorus E, Guldemont N, De Coster S, Bautmans I. Physiotherapists’ perceived motivators and barriers for organizing physical activity for older long-term care facility residents. J Am Med Directors Assoc. 2015;16(5):371–9. CrossRef Baert V, Gorus E, Guldemont N, De Coster S, Bautmans I. Physiotherapists’ perceived motivators and barriers for organizing physical activity for older long-term care facility residents. J Am Med Directors Assoc. 2015;16(5):371–9. CrossRef
Metagegevens
Titel
Spieren en spierfunctie
Auteur
Prof. dr. I. Bautmans
Copyright
2022
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-368-2783-6_5